Seeing Is Believing
Imago Biosciences's activity chart (see below) currently has 21 price targets and 14 ratings on display.
Analysts average stock forecasts to be materialized ratio is 88.89% with an average time for these price targets to be met of 150.44 days.
Most recent stock forecast was given by STEPHEN WILLEY from STIFEL on 28-Nov-2022. First documented stock forecast 10-Aug-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Aug-2021
$36
$-0.01 (-0.03%)
$36
3 years 11 months 15 days ago
(28-Nov-2022)
3/3 (100%)
$0.35 (0.98%)
267
Buy Since 15-Feb-2022
$36
$-0.01 (-0.03%)
$35
3 years 11 months 21 days ago
(22-Nov-2022)
3/4 (75%)
$0.4 (1.12%)
145
Buy Since 10-Aug-2021
$36
$-0.01 (-0.03%)
$35
3 years 11 months 21 days ago
(22-Nov-2022)
3/4 (75%)
$0.4 (1.12%)
204
Hold Since 22-Nov-2022
$36
$-0.01 (-0.03%)
3 years 11 months 22 days ago
(22-Nov-2022)
1/1 (100%)
$0.4 (1.12%)
48
Buy Since 28-Oct-2022
$36
$-0.01 (-0.03%)
$25
3 years 11 months 22 days ago
(21-Nov-2022)
2/2 (100%)
$0.41 (1.15%)
37
What is IMGO (Imago Biosciences) average time for price targets to be met?
Which analyst most recently updated their price target on IMGO (Imago Biosciences)?
Which analyst has the current lower performing score on IMGO (Imago Biosciences) with a proven track record?
Which analyst has the most public recommendations on IMGO (Imago Biosciences)?
Which analyst is the currently most bullish on IMGO (Imago Biosciences)?
Which analyst is the currently most reserved on IMGO (Imago Biosciences)?